Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune system stimulation via the Fc domain involves harnessing the interactions between the constant region of antibodies (Fc) and Fc receptors (FcRs) on immune cells or complement proteins to activate or modulate immune responses for therapeutic benefit. This includes mechanisms such as antibody-dependent cellular cytotoxicity (ADCC), phagocytosis, and complement activation. Fc engineering allows for tailoring of antibody effector functions for specific therapeutic applications in cancer, infectious diseases, and autoimmune disorders.
Activation of Fc receptors on immune cells leading to downstream effector functions such as ADCC, phagocytosis, and complement activation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Stimulation via Fc Domain.